# Screening of Non-Sterile OTC Monograph Drug Products for Microbial Contamination

Canonical: https://abierto.us/opportunities/fdacder25130338

- Solicitation number: FDA-CDER-25-130338
- Notice type: Combined synopsis and solicitation
- Status: Closed. Deadline was September 15, 2025 at 12:00 PM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Office of Acq Grant SVCS (75F401)
- NAICS: 541990 All Other Professional, Scientific, and Technical Services
- Product or service code: Q301 Reference Laboratory Testing
- Place of performance: Silver Spring, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Silver Spring. https://abierto.us/cities/silver-spring-md-2472450
- First posted: September 9, 2025
- Last posted: September 9, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/9312b78139ed4d75af24a752fe35122a/view

## Description

The overall scope of the project is to have a contract laboratory purchase and test ~70 aqueous OTC monograph drug product samples for microbial contamination using compendial test methods during the period of performance. These OTC drug products are not intended to be sterile (e.g., they are not labeled as sterile).

## Publications

- September 9, 2025: Combined synopsis and solicitation, due September 15, 2025 at 12:00 PM EDT. Notice 9312b78139ed4d75af24a752fe35122a. https://sam.gov/workspace/contract/opp/9312b78139ed4d75af24a752fe35122a/view

## Points of contact

- Rodney D. Aytch, rodney.aytch@fda.hhs.gov, 2404027515

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/fdacder25130338.